DHL Group has announced plans to invest approximately €500 million (US$575 million) over the next five years to enhance its healthcare and logistics infrastructure across Africa and the Middle East.This strategic investment aligns with DHL’s commitment to supporting the growing demand for pharmaceutical and healthcare logistics services in these regions.
The investment will target key markets including South Africa, Egypt, Kenya, Dubai, and Saudi Arabia, aiming to bolster the supply chain for high-value, time-sensitive shipments such as vaccines, stem cells, insulin therapies, and cryogenic materials. DHL plans to expand warehousing, packaging, and logistics capacity to ensure the integrity and traceability of these critical shipments. This initiative represents approximately 25% of DHL’s global €2 billion healthcare investment plan.
In addition to healthcare logistics, DHL Group will enhance its overall logistics capabilities in the Middle East, focusing on Saudi Arabia and the United Arab Emirates. The investment will span all four of DHL’s divisions—DHL Express, DHL Global Forwarding, DHL Supply Chain, and DHL eCommerce—to improve infrastructure, expand networks, and elevate service capabilities. This expansion aims to support local businesses and multinational companies operating in these high-growth markets.
The Middle East is emerging as a vital trade hub, facilitating commerce between Asia, Europe, and the U.S., while serving as a gateway to Africa. DHL’s investment underscores the region’s increasing strategic importance in global trade and the company’s commitment to supporting its transformation into a catalyst for regional and global commerce.
Read more on Tech Gist Africa:
Neuralink Secures $650 Million in Series E Funding to Advance Brain Implant Technology
Telegram Scores $300 Million xAI Deal to Integrate Grok Across One Billion Users
EIB Global, Family Bank Launch $111 Million Financing to Empower Women & Youth Entrepreneurs
